Discovery and optimisation of a covalent ligand for TRIM25 and its application to targeted protein ubiquitination
The tripartite motif (TRIM) family of RING-type E3 ligases catalyses the formation of many different types of ubiquitin chains, and as such, plays important roles in diverse cellular functions, ranging from immune regulation to cancer signalling pathways. Few ligands have been discovered for TRIM E3 ligases, and these E3s are under-represented in the rapidly expanding field of induced proximity. Here we present the identification of a novel covalent ligand for the PRYSPRY substrate binding domain of TRIM25. We employ covalent fragment screening coupled with high-throughput chemistry direct-to-biology optimisation to efficiently elaborate covalent fragment hits. We demonstrate that our optimised ligand enhances the <i>in vitro</i> auto-ubiquitination activity of TRIM25 and engages TRIM25 in live cells. We also present the X-ray crystal structure of TRIM25 PRYSPRY in complex with this covalent ligand. Finally, we incorporate our optimised ligand into heterobifunctional proximity-inducing compounds and demonstrate the <i>in vitro</i> targeted ubiquitination of a neosubstrate by TRIM25.
Authors
- Toby Mathieson (ORCID: https://orcid.org/0000-0002-6153-3113)
- Diego Esposito (ORCID: https://orcid.org/0000-0003-4042-8856)
- Thilo Werner (ORCID: https://orcid.org/0000-0003-0688-5834)
- Jacob T. Bush (ORCID: https://orcid.org/0000-0001-7165-0092)
- Katherine A. McPhie (ORCID: https://orcid.org/0000-0001-6525-7235)
- Katrin Rittinger (ORCID: https://orcid.org/0000-0002-7698-4435)
- Daniel Norman (ORCID: https://orcid.org/0000-0002-7372-7361)
- Jonathan Pettinger (ORCID: https://orcid.org/0000-0002-8219-8369)
Institutions
- University of Hertfordshire (GB)
- The Francis Crick Institute (GB)
Publication Details
- Journal
- Chemical Science
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5sc01540e
- Citations
- 8
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 6.45
Funders
- Wellcome Trust
- Francis Crick Institute
- Diamond Light Source
- Cancer Research UK
- Medical Research Council
- Engineering and Physical Sciences Research Council